Everett Magann
Concepts (800)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy | 359 | 2024 | 2609 | 12.910 |
Why?
| Amniotic Fluid | 71 | 2023 | 108 | 12.590 |
Why?
| Pregnancy Complications | 57 | 2024 | 381 | 10.630 |
Why?
| Pregnancy Outcome | 96 | 2024 | 237 | 10.190 |
Why?
| Ultrasonography, Prenatal | 69 | 2023 | 190 | 10.190 |
Why?
| Oligohydramnios | 44 | 2023 | 60 | 6.280 |
Why?
| Premature Birth | 28 | 2023 | 146 | 5.990 |
Why?
| Cesarean Section | 68 | 2024 | 185 | 5.980 |
Why?
| Obstetrics | 22 | 2022 | 88 | 5.500 |
Why?
| Female | 382 | 2024 | 26829 | 5.200 |
Why?
| Delivery, Obstetric | 45 | 2024 | 122 | 5.060 |
Why?
| Gestational Age | 80 | 2024 | 422 | 4.470 |
Why?
| Humans | 389 | 2024 | 50201 | 3.720 |
Why?
| Prenatal Care | 14 | 2023 | 108 | 3.630 |
Why?
| Polyhydramnios | 20 | 2023 | 31 | 3.520 |
Why?
| Pre-Eclampsia | 26 | 2024 | 54 | 3.500 |
Why?
| Infant, Newborn | 114 | 2024 | 2770 | 3.450 |
Why?
| Adult | 224 | 2024 | 13486 | 3.400 |
Why?
| Telemedicine | 13 | 2023 | 467 | 3.380 |
Why?
| Postpartum Hemorrhage | 12 | 2018 | 34 | 3.250 |
Why?
| Labor Stage, Third | 9 | 2018 | 19 | 3.200 |
Why?
| Placenta | 12 | 2022 | 135 | 3.100 |
Why?
| Obstetric Labor Complications | 20 | 2020 | 33 | 3.030 |
Why?
| Fetal Membranes, Premature Rupture | 7 | 2023 | 22 | 2.760 |
Why?
| Uterine Rupture | 6 | 2023 | 11 | 2.630 |
Why?
| Pregnancy, High-Risk | 16 | 2021 | 60 | 2.580 |
Why?
| Fetal Diseases | 8 | 2022 | 61 | 2.540 |
Why?
| Hypertension, Pregnancy-Induced | 6 | 2024 | 14 | 2.450 |
Why?
| Military Personnel | 15 | 2013 | 165 | 2.440 |
Why?
| HELLP Syndrome | 27 | 2007 | 27 | 2.360 |
Why?
| Twins | 19 | 2014 | 33 | 2.180 |
Why?
| Prospective Studies | 80 | 2024 | 2396 | 2.110 |
Why?
| Labor, Induced | 20 | 2020 | 25 | 2.040 |
Why?
| Birth Weight | 29 | 2020 | 121 | 2.010 |
Why?
| Pregnancy Complications, Cardiovascular | 13 | 2024 | 36 | 1.980 |
Why?
| Risk Factors | 57 | 2023 | 3644 | 1.860 |
Why?
| Diabetes, Gestational | 6 | 2024 | 52 | 1.830 |
Why?
| Hypertension | 18 | 2024 | 541 | 1.810 |
Why?
| Pregnancy Complications, Neoplastic | 3 | 2024 | 24 | 1.700 |
Why?
| Parturition | 8 | 2023 | 49 | 1.680 |
Why?
| Labor, Obstetric | 16 | 2023 | 44 | 1.640 |
Why?
| Fetal Growth Retardation | 15 | 2016 | 42 | 1.630 |
Why?
| Gynecology | 8 | 2022 | 49 | 1.580 |
Why?
| Infant, Small for Gestational Age | 13 | 2024 | 34 | 1.560 |
Why?
| Obstetric Labor, Premature | 18 | 2016 | 38 | 1.550 |
Why?
| Retrospective Studies | 68 | 2023 | 6190 | 1.430 |
Why?
| Postpartum Period | 16 | 2024 | 110 | 1.410 |
Why?
| Surgical Wound Dehiscence | 4 | 2021 | 20 | 1.360 |
Why?
| Pregnancy, Abdominal | 3 | 2015 | 10 | 1.360 |
Why?
| Vaginal Birth after Cesarean | 6 | 2023 | 9 | 1.330 |
Why?
| Pregnancy Trimester, Third | 18 | 2022 | 63 | 1.310 |
Why?
| Uterine Diseases | 4 | 2020 | 10 | 1.310 |
Why?
| Hemorrhage | 7 | 2023 | 196 | 1.290 |
Why?
| Dye Dilution Technique | 9 | 2014 | 18 | 1.280 |
Why?
| Ultrasonography | 20 | 2023 | 438 | 1.270 |
Why?
| Congenital Abnormalities | 7 | 2021 | 115 | 1.260 |
Why?
| Rural Health Services | 4 | 2016 | 168 | 1.260 |
Why?
| Young Adult | 40 | 2024 | 4052 | 1.240 |
Why?
| Domestic Violence | 4 | 2012 | 21 | 1.200 |
Why?
| Obesity, Morbid | 4 | 2018 | 77 | 1.190 |
Why?
| Peripartum Period | 4 | 2022 | 15 | 1.180 |
Why?
| Abortion, Spontaneous | 2 | 2022 | 16 | 1.170 |
Why?
| Fetal Distress | 21 | 2020 | 22 | 1.160 |
Why?
| Pregnancy Complications, Infectious | 6 | 2021 | 76 | 1.160 |
Why?
| Ultrasonography, Doppler, Color | 5 | 2019 | 32 | 1.150 |
Why?
| Fetal Weight | 8 | 2014 | 12 | 1.150 |
Why?
| Fetal Death | 7 | 2022 | 23 | 1.140 |
Why?
| Fetus | 7 | 2020 | 218 | 1.110 |
Why?
| Cervical Ripening | 8 | 2016 | 9 | 1.100 |
Why?
| Uterus | 10 | 2023 | 91 | 1.060 |
Why?
| Pregnancy Complications, Hematologic | 6 | 2021 | 15 | 1.050 |
Why?
| Parity | 21 | 2020 | 50 | 1.040 |
Why?
| Adolescent | 56 | 2022 | 6459 | 1.010 |
Why?
| Dystocia | 9 | 2014 | 10 | 0.990 |
Why?
| Maternal Mortality | 6 | 2020 | 25 | 0.990 |
Why?
| Fetal Macrosomia | 12 | 2015 | 20 | 0.980 |
Why?
| Morbidity | 8 | 2023 | 132 | 0.970 |
Why?
| Body Mass Index | 13 | 2020 | 658 | 0.970 |
Why?
| Referral and Consultation | 5 | 2015 | 284 | 0.960 |
Why?
| Surgical Wound Infection | 7 | 2017 | 116 | 0.950 |
Why?
| Time Factors | 35 | 2024 | 2909 | 0.930 |
Why?
| Uterine Prolapse | 1 | 2023 | 3 | 0.890 |
Why?
| Umbilical Cord | 2 | 2020 | 35 | 0.890 |
Why?
| Mass Screening | 5 | 2012 | 348 | 0.890 |
Why?
| Cervix Uteri | 9 | 2014 | 48 | 0.880 |
Why?
| Pelvic Girdle Pain | 1 | 2023 | 2 | 0.870 |
Why?
| Esophageal Neoplasms | 1 | 2024 | 104 | 0.870 |
Why?
| Pregnancy, Multiple | 6 | 2007 | 23 | 0.870 |
Why?
| Antihypertensive Agents | 4 | 2024 | 126 | 0.860 |
Why?
| Adrenal Gland Diseases | 1 | 2023 | 8 | 0.840 |
Why?
| Health Services Accessibility | 4 | 2021 | 420 | 0.840 |
Why?
| Adrenal Insufficiency | 1 | 2023 | 18 | 0.840 |
Why?
| Adenomyosis | 1 | 2022 | 1 | 0.830 |
Why?
| Adrenal Cortex Hormones | 4 | 2017 | 100 | 0.830 |
Why?
| Prenatal Diagnosis | 7 | 2022 | 108 | 0.820 |
Why?
| Maternal Death | 1 | 2022 | 7 | 0.810 |
Why?
| Rural Population | 4 | 2022 | 551 | 0.800 |
Why?
| Blood Loss, Surgical | 7 | 2012 | 73 | 0.800 |
Why?
| Cystitis | 1 | 2022 | 17 | 0.790 |
Why?
| Health Status Disparities | 2 | 2022 | 196 | 0.790 |
Why?
| Respiratory Distress Syndrome, Newborn | 8 | 2017 | 52 | 0.780 |
Why?
| Hyperparathyroidism | 1 | 2022 | 31 | 0.770 |
Why?
| Arkansas | 14 | 2022 | 1988 | 0.770 |
Why?
| Obesity | 8 | 2020 | 1112 | 0.770 |
Why?
| Postmenopause | 1 | 2022 | 76 | 0.760 |
Why?
| Privacy | 1 | 2021 | 16 | 0.750 |
Why?
| Stomach Neoplasms | 1 | 2024 | 187 | 0.750 |
Why?
| Communication Barriers | 1 | 2021 | 31 | 0.740 |
Why?
| Spinal Cord Injuries | 1 | 2021 | 53 | 0.720 |
Why?
| Practice Guidelines as Topic | 10 | 2020 | 459 | 0.720 |
Why?
| Predictive Value of Tests | 29 | 2019 | 921 | 0.700 |
Why?
| Torsion Abnormality | 1 | 2020 | 4 | 0.700 |
Why?
| Education, Medical | 1 | 2022 | 112 | 0.700 |
Why?
| Pregnancy, Twin | 3 | 2014 | 8 | 0.690 |
Why?
| Medically Underserved Area | 1 | 2020 | 42 | 0.690 |
Why?
| Carcinoma, Signet Ring Cell | 1 | 2019 | 14 | 0.680 |
Why?
| Placenta Diseases | 1 | 2019 | 14 | 0.670 |
Why?
| Dexamethasone | 9 | 2016 | 434 | 0.670 |
Why?
| Health Personnel | 2 | 2020 | 250 | 0.660 |
Why?
| Fetal Monitoring | 10 | 2013 | 42 | 0.660 |
Why?
| Disease Management | 1 | 2021 | 175 | 0.660 |
Why?
| Simplexvirus | 1 | 2019 | 11 | 0.650 |
Why?
| Urinary Bladder Calculi | 1 | 2018 | 4 | 0.640 |
Why?
| Women's Health Services | 1 | 2019 | 15 | 0.640 |
Why?
| Herpes Simplex | 1 | 2019 | 21 | 0.640 |
Why?
| Heart Rate, Fetal | 15 | 2016 | 73 | 0.640 |
Why?
| Military Medicine | 1 | 2019 | 23 | 0.640 |
Why?
| Lymphatic Metastasis | 1 | 2019 | 226 | 0.630 |
Why?
| Pregnancy Trimester, Second | 13 | 2020 | 27 | 0.630 |
Why?
| Fetal Mortality | 3 | 2015 | 7 | 0.630 |
Why?
| Uterine Inversion | 1 | 2018 | 1 | 0.620 |
Why?
| Stillbirth | 4 | 2022 | 29 | 0.620 |
Why?
| Mississippi | 12 | 2015 | 88 | 0.610 |
Why?
| Fetal Blood | 11 | 2010 | 71 | 0.610 |
Why?
| Intensive Care Units, Neonatal | 3 | 2015 | 119 | 0.610 |
Why?
| Sensitivity and Specificity | 23 | 2017 | 871 | 0.610 |
Why?
| Women, Working | 2 | 2012 | 4 | 0.600 |
Why?
| Magnesium Sulfate | 8 | 2016 | 13 | 0.600 |
Why?
| Patient Satisfaction | 3 | 2023 | 280 | 0.590 |
Why?
| Diverticulum | 1 | 2017 | 21 | 0.580 |
Why?
| Blood Pressure | 11 | 2024 | 527 | 0.580 |
Why?
| Internship and Residency | 2 | 2022 | 443 | 0.580 |
Why?
| Infant, Premature | 5 | 2015 | 319 | 0.560 |
Why?
| Stroke | 1 | 2022 | 479 | 0.560 |
Why?
| Apgar Score | 20 | 2018 | 34 | 0.560 |
Why?
| Imaging, Three-Dimensional | 2 | 2019 | 152 | 0.550 |
Why?
| Uterine Retroversion | 1 | 2016 | 2 | 0.550 |
Why?
| Infant Mortality | 10 | 2013 | 60 | 0.550 |
Why?
| Brachial Plexus Neuropathies | 2 | 2014 | 10 | 0.540 |
Why?
| Fish Products | 1 | 2016 | 2 | 0.530 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2016 | 4 | 0.530 |
Why?
| Gastroschisis | 1 | 2016 | 38 | 0.530 |
Why?
| Reproducibility of Results | 14 | 2021 | 1195 | 0.530 |
Why?
| Foodborne Diseases | 1 | 2016 | 12 | 0.530 |
Why?
| Pregnant Women | 4 | 2023 | 76 | 0.530 |
Why?
| Genetic Counseling | 1 | 2016 | 40 | 0.530 |
Why?
| Respiration Disorders | 1 | 2015 | 23 | 0.510 |
Why?
| Genetic Testing | 1 | 2016 | 119 | 0.510 |
Why?
| Hydroxyprogesterones | 4 | 2021 | 7 | 0.510 |
Why?
| Adenocarcinoma | 1 | 2019 | 402 | 0.510 |
Why?
| Death Certificates | 1 | 2015 | 17 | 0.500 |
Why?
| Birth Certificates | 1 | 2015 | 20 | 0.500 |
Why?
| Tertiary Care Centers | 2 | 2015 | 76 | 0.500 |
Why?
| Odds Ratio | 9 | 2016 | 548 | 0.500 |
Why?
| Tocolysis | 5 | 2015 | 5 | 0.500 |
Why?
| Nifedipine | 4 | 2024 | 25 | 0.490 |
Why?
| Uterine Hemorrhage | 4 | 2021 | 11 | 0.490 |
Why?
| Exercise | 3 | 2009 | 504 | 0.490 |
Why?
| Regression Analysis | 13 | 2018 | 395 | 0.490 |
Why?
| Monitoring, Ambulatory | 1 | 2015 | 7 | 0.490 |
Why?
| Catheterization | 3 | 2011 | 100 | 0.490 |
Why?
| Randomized Controlled Trials as Topic | 8 | 2021 | 553 | 0.480 |
Why?
| Tocolytic Agents | 6 | 2015 | 8 | 0.480 |
Why?
| Magnetic Resonance Imaging | 4 | 2022 | 1529 | 0.480 |
Why?
| Chorionic Gonadotropin | 1 | 2014 | 18 | 0.480 |
Why?
| Spouse Abuse | 3 | 2012 | 10 | 0.470 |
Why?
| Pregnancy Trimester, First | 1 | 2014 | 22 | 0.470 |
Why?
| Fractures, Bone | 3 | 2014 | 106 | 0.470 |
Why?
| Automobile Driving | 1 | 2014 | 22 | 0.470 |
Why?
| Prevalence | 10 | 2023 | 960 | 0.470 |
Why?
| Dinoprostone | 6 | 2002 | 53 | 0.460 |
Why?
| Lung Neoplasms | 2 | 2019 | 601 | 0.460 |
Why?
| Pregnancy, Prolonged | 5 | 2008 | 6 | 0.450 |
Why?
| Multivariate Analysis | 8 | 2015 | 581 | 0.450 |
Why?
| United States | 20 | 2023 | 4898 | 0.440 |
Why?
| Endometritis | 7 | 2010 | 9 | 0.440 |
Why?
| Posture | 2 | 2005 | 60 | 0.440 |
Why?
| Triage | 5 | 2024 | 61 | 0.440 |
Why?
| Algorithms | 4 | 2013 | 615 | 0.430 |
Why?
| Truth Disclosure | 1 | 2013 | 14 | 0.430 |
Why?
| Guideline Adherence | 3 | 2013 | 133 | 0.430 |
Why?
| Incidence | 16 | 2020 | 1000 | 0.430 |
Why?
| Case-Control Studies | 14 | 2023 | 1145 | 0.420 |
Why?
| Eclampsia | 7 | 2003 | 7 | 0.420 |
Why?
| Pilot Projects | 5 | 2022 | 703 | 0.410 |
Why?
| Brain Injuries | 1 | 2014 | 159 | 0.410 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2013 | 105 | 0.400 |
Why?
| Ideal Body Weight | 1 | 2012 | 6 | 0.400 |
Why?
| Body Weights and Measures | 1 | 2012 | 17 | 0.400 |
Why?
| Rupture, Spontaneous | 3 | 2022 | 20 | 0.400 |
Why?
| Middle Aged | 16 | 2022 | 12356 | 0.400 |
Why?
| Blood Transfusion | 5 | 2021 | 127 | 0.390 |
Why?
| Treatment Outcome | 15 | 2024 | 5203 | 0.390 |
Why?
| Amniocentesis | 11 | 2004 | 14 | 0.390 |
Why?
| Diagnosis, Differential | 7 | 2019 | 1041 | 0.380 |
Why?
| Oxytocin | 3 | 2005 | 19 | 0.380 |
Why?
| Gravidity | 3 | 2020 | 5 | 0.380 |
Why?
| Acidosis | 7 | 2004 | 40 | 0.380 |
Why?
| Reference Values | 10 | 2019 | 309 | 0.380 |
Why?
| Cohort Studies | 14 | 2021 | 1414 | 0.380 |
Why?
| Contraception | 1 | 2011 | 29 | 0.380 |
Why?
| Intrauterine Devices, Medicated | 1 | 2011 | 1 | 0.380 |
Why?
| Levonorgestrel | 1 | 2011 | 4 | 0.370 |
Why?
| Puerperal Disorders | 8 | 2015 | 28 | 0.370 |
Why?
| Clinical Competence | 4 | 2022 | 397 | 0.370 |
Why?
| Umbilical Arteries | 12 | 2006 | 22 | 0.360 |
Why?
| Fluid Therapy | 2 | 2018 | 75 | 0.360 |
Why?
| Aerospace Medicine | 1 | 2010 | 3 | 0.360 |
Why?
| Terbutaline | 3 | 2008 | 7 | 0.350 |
Why?
| Quality of Life | 3 | 2023 | 843 | 0.350 |
Why?
| Oxytocics | 4 | 2016 | 7 | 0.330 |
Why?
| Battered Women | 1 | 2009 | 3 | 0.330 |
Why?
| Amnion | 5 | 2020 | 11 | 0.330 |
Why?
| Hospitalization | 5 | 2024 | 665 | 0.320 |
Why?
| Lung | 6 | 2011 | 507 | 0.320 |
Why?
| Chi-Square Distribution | 9 | 2012 | 280 | 0.320 |
Why?
| Coloring Agents | 4 | 2004 | 70 | 0.320 |
Why?
| Anemia, Sickle Cell | 2 | 2021 | 94 | 0.320 |
Why?
| Birth Injuries | 5 | 2013 | 11 | 0.310 |
Why?
| Bibliometrics | 1 | 2008 | 16 | 0.310 |
Why?
| Fibronectins | 3 | 2011 | 39 | 0.310 |
Why?
| Medicaid | 5 | 2023 | 256 | 0.300 |
Why?
| Progestins | 3 | 2014 | 10 | 0.300 |
Why?
| Publishing | 1 | 2008 | 38 | 0.300 |
Why?
| Infant, Newborn, Diseases | 3 | 2014 | 57 | 0.300 |
Why?
| Chorioamnionitis | 4 | 2017 | 15 | 0.300 |
Why?
| Extraembryonic Membranes | 4 | 2001 | 5 | 0.290 |
Why?
| Homocysteine | 1 | 2008 | 127 | 0.290 |
Why?
| ROC Curve | 15 | 2016 | 236 | 0.290 |
Why?
| Risk Assessment | 9 | 2019 | 1255 | 0.270 |
Why?
| Hospitals | 2 | 2020 | 172 | 0.270 |
Why?
| Prognosis | 8 | 2018 | 1963 | 0.270 |
Why?
| Hydrogen-Ion Concentration | 14 | 2011 | 177 | 0.270 |
Why?
| Hypercalcemia | 1 | 2006 | 33 | 0.270 |
Why?
| Puerperal Infection | 4 | 2005 | 6 | 0.270 |
Why?
| Logistic Models | 7 | 2011 | 901 | 0.270 |
Why?
| Renal Insufficiency | 2 | 2006 | 108 | 0.260 |
Why?
| Remote Consultation | 2 | 2017 | 29 | 0.260 |
Why?
| Brachial Plexus | 5 | 2013 | 13 | 0.260 |
Why?
| Maternal Age | 6 | 2015 | 43 | 0.260 |
Why?
| Body Weight | 3 | 2013 | 513 | 0.260 |
Why?
| Version, Fetal | 1 | 2005 | 1 | 0.260 |
Why?
| Platelet Count | 10 | 2001 | 74 | 0.260 |
Why?
| Lifting | 1 | 2005 | 2 | 0.260 |
Why?
| Cerebral Palsy | 3 | 2016 | 39 | 0.250 |
Why?
| Exercise Therapy | 2 | 2023 | 94 | 0.250 |
Why?
| Smoking | 4 | 2018 | 506 | 0.250 |
Why?
| Placenta, Retained | 3 | 2016 | 4 | 0.250 |
Why?
| Noise | 1 | 2005 | 38 | 0.250 |
Why?
| Male | 17 | 2022 | 25572 | 0.240 |
Why?
| Labetalol | 1 | 2024 | 2 | 0.240 |
Why?
| Chorion | 1 | 2004 | 1 | 0.230 |
Why?
| Noise, Occupational | 1 | 2024 | 3 | 0.230 |
Why?
| Intensive Care, Neonatal | 2 | 2003 | 23 | 0.230 |
Why?
| Patient Care Team | 3 | 2021 | 258 | 0.230 |
Why?
| Depression | 3 | 2017 | 571 | 0.230 |
Why?
| Labor Stage, First | 5 | 2015 | 9 | 0.220 |
Why?
| Home Infusion Therapy | 1 | 2003 | 1 | 0.220 |
Why?
| Weight Gain | 4 | 2013 | 234 | 0.220 |
Why?
| Urinary Tract Infections | 1 | 2023 | 51 | 0.220 |
Why?
| Confidence Intervals | 5 | 2016 | 155 | 0.210 |
Why?
| Blood Volume | 2 | 2018 | 69 | 0.210 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2010 | 484 | 0.210 |
Why?
| Chorionic Villi | 2 | 2019 | 3 | 0.210 |
Why?
| International Classification of Diseases | 2 | 2015 | 64 | 0.210 |
Why?
| Aminohippuric Acids | 2 | 2002 | 2 | 0.210 |
Why?
| Marital Status | 2 | 2009 | 19 | 0.210 |
Why?
| Abortion, Therapeutic | 1 | 2002 | 3 | 0.210 |
Why?
| Anticonvulsants | 3 | 2016 | 125 | 0.210 |
Why?
| Energy Metabolism | 2 | 2013 | 284 | 0.210 |
Why?
| Pubic Symphysis | 2 | 2015 | 3 | 0.200 |
Why?
| Exudates and Transudates | 1 | 2002 | 4 | 0.200 |
Why?
| Hospitals, Military | 2 | 2014 | 7 | 0.200 |
Why?
| Intrauterine Devices | 2 | 2012 | 4 | 0.200 |
Why?
| Mandatory Reporting | 2 | 2012 | 12 | 0.200 |
Why?
| Sutures | 1 | 2002 | 39 | 0.200 |
Why?
| Hospitals, Teaching | 2 | 2020 | 53 | 0.200 |
Why?
| Embryo Implantation | 1 | 2002 | 7 | 0.200 |
Why?
| Acute Disease | 2 | 2022 | 368 | 0.200 |
Why?
| Drainage | 1 | 2002 | 79 | 0.200 |
Why?
| Hematoma | 1 | 2002 | 64 | 0.200 |
Why?
| Emergency Service, Hospital | 2 | 2024 | 482 | 0.190 |
Why?
| Anti-Inflammatory Agents | 2 | 2000 | 162 | 0.190 |
Why?
| Licensure | 1 | 2021 | 14 | 0.190 |
Why?
| Mothers | 2 | 2017 | 256 | 0.190 |
Why?
| Health Insurance Portability and Accountability Act | 1 | 2021 | 13 | 0.190 |
Why?
| South Carolina | 3 | 2015 | 23 | 0.190 |
Why?
| Term Birth | 3 | 2015 | 16 | 0.190 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 110 | 0.190 |
Why?
| Technology | 1 | 2021 | 20 | 0.190 |
Why?
| Reproductive Health | 1 | 2021 | 8 | 0.190 |
Why?
| Uterine Contraction | 3 | 2008 | 37 | 0.190 |
Why?
| Risk Adjustment | 1 | 2021 | 16 | 0.190 |
Why?
| Infant | 6 | 2023 | 3584 | 0.180 |
Why?
| Chronic Disease | 5 | 2024 | 568 | 0.180 |
Why?
| Fatal Outcome | 2 | 2019 | 195 | 0.180 |
Why?
| Hysterectomy | 4 | 2021 | 88 | 0.180 |
Why?
| Antithrombin Proteins | 1 | 2020 | 1 | 0.180 |
Why?
| Placenta Accreta | 1 | 2021 | 25 | 0.180 |
Why?
| Prolapse | 1 | 2020 | 6 | 0.180 |
Why?
| Sleep | 1 | 2002 | 179 | 0.180 |
Why?
| Maternal Health Services | 1 | 2021 | 29 | 0.180 |
Why?
| Postoperative Complications | 8 | 2017 | 1027 | 0.180 |
Why?
| Probability | 6 | 2008 | 164 | 0.180 |
Why?
| Biophysical Phenomena | 3 | 2014 | 19 | 0.180 |
Why?
| Patient Care Planning | 1 | 2020 | 67 | 0.170 |
Why?
| Quality Improvement | 1 | 2022 | 206 | 0.170 |
Why?
| Surrogate Mothers | 1 | 2019 | 4 | 0.170 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 1580 | 0.170 |
Why?
| Chest Pain | 1 | 2019 | 55 | 0.170 |
Why?
| L-Lactate Dehydrogenase | 7 | 2001 | 70 | 0.170 |
Why?
| Uterine Cervical Incompetence | 2 | 2011 | 2 | 0.170 |
Why?
| Misoprostol | 3 | 2016 | 5 | 0.170 |
Why?
| Cerclage, Cervical | 2 | 2011 | 8 | 0.170 |
Why?
| Dyspnea | 1 | 2019 | 74 | 0.170 |
Why?
| Abdominal Pain | 1 | 2020 | 84 | 0.160 |
Why?
| Honduras | 1 | 2019 | 1 | 0.160 |
Why?
| Guatemala | 1 | 2019 | 4 | 0.160 |
Why?
| Mental Health Services | 1 | 2022 | 198 | 0.160 |
Why?
| Office Visits | 2 | 2013 | 41 | 0.160 |
Why?
| Contraception Behavior | 1 | 2019 | 10 | 0.160 |
Why?
| Colombia | 1 | 2019 | 15 | 0.160 |
Why?
| Acyclovir | 1 | 2019 | 9 | 0.160 |
Why?
| Lithotripsy, Laser | 1 | 2018 | 6 | 0.160 |
Why?
| Tomography, X-Ray Computed | 3 | 2022 | 1160 | 0.160 |
Why?
| Infant, Premature, Diseases | 3 | 2020 | 94 | 0.160 |
Why?
| Critical Illness | 1 | 2021 | 301 | 0.160 |
Why?
| Australia | 3 | 2012 | 83 | 0.160 |
Why?
| Internet | 1 | 2021 | 261 | 0.160 |
Why?
| Child | 2 | 2023 | 6862 | 0.160 |
Why?
| Estradiol | 2 | 2002 | 215 | 0.160 |
Why?
| Medical Records | 4 | 2014 | 86 | 0.160 |
Why?
| Obstetric Surgical Procedures | 1 | 2018 | 2 | 0.160 |
Why?
| Wounds and Injuries | 3 | 2009 | 281 | 0.160 |
Why?
| Cell Adhesion Molecules | 1 | 2019 | 87 | 0.160 |
Why?
| Vaginosis, Bacterial | 2 | 2011 | 8 | 0.150 |
Why?
| Linear Models | 7 | 2021 | 279 | 0.150 |
Why?
| Seasons | 1 | 1998 | 81 | 0.150 |
Why?
| Temperature | 2 | 1998 | 165 | 0.150 |
Why?
| Fetal Development | 2 | 2016 | 59 | 0.150 |
Why?
| Early Diagnosis | 1 | 2018 | 88 | 0.150 |
Why?
| Age Factors | 3 | 2011 | 1096 | 0.150 |
Why?
| Glucose Tolerance Test | 2 | 2010 | 56 | 0.150 |
Why?
| Heart Defects, Congenital | 1 | 2023 | 590 | 0.150 |
Why?
| Aged | 3 | 2022 | 9505 | 0.150 |
Why?
| Trial of Labor | 6 | 2008 | 6 | 0.140 |
Why?
| Severity of Illness Index | 7 | 2010 | 959 | 0.140 |
Why?
| Emergency Medical Services | 2 | 2012 | 111 | 0.140 |
Why?
| Medical Laboratory Personnel | 1 | 1997 | 4 | 0.140 |
Why?
| Proportional Hazards Models | 2 | 2015 | 408 | 0.140 |
Why?
| Pyelonephritis | 1 | 2017 | 5 | 0.140 |
Why?
| Antiviral Agents | 1 | 2019 | 168 | 0.140 |
Why?
| Actinomyces | 1 | 2017 | 9 | 0.140 |
Why?
| Actinomycosis | 1 | 2017 | 10 | 0.140 |
Why?
| Indomethacin | 2 | 2015 | 38 | 0.140 |
Why?
| Cesarean Section, Repeat | 3 | 2003 | 7 | 0.140 |
Why?
| Professional Competence | 1 | 1997 | 41 | 0.140 |
Why?
| Self-Injurious Behavior | 1 | 2017 | 28 | 0.140 |
Why?
| Malpractice | 2 | 2008 | 15 | 0.140 |
Why?
| Kidney | 1 | 2021 | 677 | 0.140 |
Why?
| Antioxidants | 1 | 2019 | 237 | 0.140 |
Why?
| Fetal Organ Maturity | 5 | 2000 | 9 | 0.140 |
Why?
| Reactive Oxygen Species | 1 | 2019 | 406 | 0.140 |
Why?
| Telephone | 2 | 2017 | 70 | 0.140 |
Why?
| Hematocrit | 3 | 2012 | 45 | 0.140 |
Why?
| Betamethasone | 3 | 2016 | 5 | 0.140 |
Why?
| Brain Waves | 1 | 2016 | 18 | 0.140 |
Why?
| Symptom Assessment | 1 | 2016 | 32 | 0.140 |
Why?
| Patient Care Management | 1 | 2016 | 18 | 0.140 |
Why?
| Systole | 1 | 2016 | 71 | 0.140 |
Why?
| Hospitals, University | 3 | 2014 | 78 | 0.130 |
Why?
| Intestinal Diseases, Parasitic | 1 | 2016 | 3 | 0.130 |
Why?
| Suicidal Ideation | 1 | 2017 | 98 | 0.130 |
Why?
| Socioeconomic Factors | 2 | 2016 | 584 | 0.130 |
Why?
| Colposcopy | 1 | 2016 | 18 | 0.130 |
Why?
| Pubic Symphysis Diastasis | 1 | 2015 | 2 | 0.130 |
Why?
| Hospitals, Community | 2 | 2014 | 19 | 0.130 |
Why?
| Humeral Fractures | 2 | 2013 | 8 | 0.130 |
Why?
| Clavicle | 2 | 2013 | 6 | 0.130 |
Why?
| Employment | 1 | 1996 | 89 | 0.130 |
Why?
| Twins, Dizygotic | 1 | 1995 | 6 | 0.130 |
Why?
| Urologic Diseases | 1 | 2015 | 10 | 0.130 |
Why?
| Neuroprotective Agents | 1 | 2016 | 100 | 0.130 |
Why?
| Magnetoencephalography | 1 | 2016 | 117 | 0.120 |
Why?
| Language Development Disorders | 1 | 2015 | 18 | 0.120 |
Why?
| Pregnancy in Diabetics | 4 | 2010 | 28 | 0.120 |
Why?
| Humidity | 1 | 1995 | 4 | 0.120 |
Why?
| Insulin | 2 | 2007 | 460 | 0.120 |
Why?
| Follow-Up Studies | 7 | 2017 | 2188 | 0.120 |
Why?
| Drug Implants | 2 | 2011 | 35 | 0.120 |
Why?
| Animal Assisted Therapy | 1 | 2014 | 3 | 0.120 |
Why?
| Episiotomy | 1 | 2014 | 6 | 0.120 |
Why?
| Progesterone | 1 | 2014 | 55 | 0.120 |
Why?
| Sheep | 1 | 2014 | 91 | 0.120 |
Why?
| Safety | 1 | 2015 | 77 | 0.120 |
Why?
| Southwestern United States | 1 | 2014 | 16 | 0.120 |
Why?
| Naval Medicine | 2 | 2009 | 5 | 0.120 |
Why?
| Louisiana | 1 | 2014 | 39 | 0.120 |
Why?
| Stress, Psychological | 3 | 2008 | 260 | 0.120 |
Why?
| Southeastern United States | 1 | 2014 | 46 | 0.120 |
Why?
| Oxidative Stress | 1 | 2019 | 763 | 0.120 |
Why?
| Physician-Patient Relations | 2 | 2013 | 143 | 0.110 |
Why?
| Clinical Protocols | 2 | 2012 | 109 | 0.110 |
Why?
| Calcium Channel Blockers | 1 | 1994 | 64 | 0.110 |
Why?
| Health Care Costs | 1 | 2015 | 168 | 0.110 |
Why?
| Academic Medical Centers | 1 | 2014 | 147 | 0.110 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 270 | 0.110 |
Why?
| Analysis of Variance | 7 | 2001 | 563 | 0.110 |
Why?
| Xylenes | 1 | 1993 | 3 | 0.110 |
Why?
| Insulin-Like Growth Factor II | 2 | 2010 | 19 | 0.110 |
Why?
| Premedication | 1 | 1993 | 17 | 0.110 |
Why?
| Cefazolin | 1 | 1993 | 11 | 0.110 |
Why?
| Healthy People Programs | 1 | 2013 | 4 | 0.110 |
Why?
| Brain Diseases | 2 | 2005 | 80 | 0.110 |
Why?
| Curettage | 1 | 1993 | 13 | 0.110 |
Why?
| Counseling | 1 | 2014 | 132 | 0.110 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 173 | 0.110 |
Why?
| Data Collection | 2 | 2012 | 283 | 0.110 |
Why?
| Depression, Postpartum | 1 | 2013 | 42 | 0.110 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 277 | 0.110 |
Why?
| Intraoperative Care | 1 | 1993 | 52 | 0.110 |
Why?
| Image Enhancement | 1 | 2013 | 54 | 0.110 |
Why?
| Placenta Previa | 1 | 1993 | 6 | 0.110 |
Why?
| Anti-Infective Agents, Local | 1 | 1993 | 28 | 0.110 |
Why?
| Adnexa Uteri | 1 | 2012 | 1 | 0.110 |
Why?
| Digestive System | 1 | 2012 | 15 | 0.100 |
Why?
| Retroperitoneal Space | 1 | 2012 | 32 | 0.100 |
Why?
| Patient Admission | 2 | 2005 | 74 | 0.100 |
Why?
| Abdominal Wall | 1 | 2012 | 12 | 0.100 |
Why?
| Peritoneum | 1 | 2012 | 17 | 0.100 |
Why?
| Abdomen | 4 | 2006 | 77 | 0.100 |
Why?
| Government Agencies | 1 | 2012 | 14 | 0.100 |
Why?
| Birth Rate | 1 | 2012 | 4 | 0.100 |
Why?
| Hemoglobins | 1 | 2013 | 106 | 0.100 |
Why?
| Local Government | 1 | 2012 | 23 | 0.100 |
Why?
| Return to Work | 1 | 2012 | 11 | 0.100 |
Why?
| Attitude of Health Personnel | 3 | 2012 | 348 | 0.100 |
Why?
| Reference Standards | 1 | 2012 | 52 | 0.100 |
Why?
| Patient Care | 1 | 2012 | 57 | 0.100 |
Why?
| Motor Activity | 1 | 2013 | 222 | 0.100 |
Why?
| Anxiety | 1 | 2014 | 276 | 0.100 |
Why?
| Administration, Oral | 3 | 2024 | 432 | 0.100 |
Why?
| Administration, Intravaginal | 4 | 2014 | 7 | 0.100 |
Why?
| Desogestrel | 1 | 2011 | 2 | 0.100 |
Why?
| Urination | 1 | 2011 | 19 | 0.100 |
Why?
| Contraceptive Agents, Female | 1 | 2011 | 5 | 0.100 |
Why?
| Emotions | 1 | 2013 | 165 | 0.100 |
Why?
| Osmolar Concentration | 1 | 2011 | 63 | 0.100 |
Why?
| Reproductive History | 1 | 2011 | 4 | 0.100 |
Why?
| Drug Eruptions | 1 | 2011 | 13 | 0.100 |
Why?
| Breech Presentation | 2 | 2005 | 2 | 0.100 |
Why?
| Traction | 1 | 2011 | 7 | 0.100 |
Why?
| Hypoxia-Ischemia, Brain | 2 | 2010 | 55 | 0.100 |
Why?
| Personal Satisfaction | 1 | 2012 | 77 | 0.100 |
Why?
| Guidelines as Topic | 1 | 2012 | 110 | 0.100 |
Why?
| Surgical Sponges | 1 | 2011 | 6 | 0.100 |
Why?
| Labor Stage, Second | 2 | 2008 | 3 | 0.090 |
Why?
| Periodicals as Topic | 2 | 2010 | 57 | 0.090 |
Why?
| Deglutition | 1 | 2011 | 40 | 0.090 |
Why?
| Fetal Proteins | 1 | 2011 | 4 | 0.090 |
Why?
| Medical Errors | 1 | 2011 | 23 | 0.090 |
Why?
| Infusions, Intravenous | 2 | 2003 | 213 | 0.090 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 2011 | 1 | 0.090 |
Why?
| Communication | 1 | 2013 | 246 | 0.090 |
Why?
| Weight-Bearing | 1 | 2011 | 46 | 0.090 |
Why?
| Genomic Imprinting | 2 | 2007 | 11 | 0.090 |
Why?
| Metronidazole | 1 | 2011 | 27 | 0.090 |
Why?
| Receptor, IGF Type 2 | 1 | 2010 | 7 | 0.090 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 489 | 0.090 |
Why?
| Family Practice | 1 | 2012 | 101 | 0.090 |
Why?
| Appendicitis | 2 | 2009 | 62 | 0.090 |
Why?
| Hemostasis, Surgical | 2 | 2005 | 12 | 0.090 |
Why?
| Hemodynamics | 1 | 2012 | 264 | 0.090 |
Why?
| Qualitative Research | 1 | 2013 | 337 | 0.090 |
Why?
| RNA, Untranslated | 1 | 2010 | 14 | 0.090 |
Why?
| Hypersensitivity | 1 | 2011 | 75 | 0.090 |
Why?
| Foreign Bodies | 1 | 2011 | 63 | 0.090 |
Why?
| Longitudinal Studies | 2 | 2011 | 700 | 0.090 |
Why?
| Length of Stay | 3 | 2021 | 627 | 0.090 |
Why?
| Aviation | 1 | 2010 | 5 | 0.090 |
Why?
| Haplotypes | 2 | 2007 | 84 | 0.090 |
Why?
| Seizures | 2 | 2003 | 195 | 0.090 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 3 | 0.090 |
Why?
| Anti-Bacterial Agents | 3 | 2023 | 744 | 0.090 |
Why?
| Monitoring, Physiologic | 1 | 2011 | 127 | 0.090 |
Why?
| Heart Diseases | 2 | 2005 | 211 | 0.090 |
Why?
| Fetal Movement | 2 | 2000 | 20 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2011 | 95 | 0.090 |
Why?
| Child, Preschool | 2 | 2015 | 3896 | 0.090 |
Why?
| Pelvis | 2 | 2015 | 67 | 0.090 |
Why?
| Physical Examination | 3 | 2003 | 95 | 0.080 |
Why?
| Perinatal Care | 2 | 2020 | 26 | 0.080 |
Why?
| Cardiac Complexes, Premature | 1 | 2009 | 3 | 0.080 |
Why?
| Clothing | 1 | 2009 | 4 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 68 | 0.080 |
Why?
| Meconium | 2 | 1999 | 4 | 0.080 |
Why?
| Exercise Tolerance | 1 | 2009 | 40 | 0.080 |
Why?
| Social Perception | 1 | 2009 | 27 | 0.080 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2009 | 2 | 0.080 |
Why?
| Physicians | 2 | 2012 | 229 | 0.080 |
Why?
| Suppositories | 3 | 2015 | 3 | 0.080 |
Why?
| Physician's Role | 1 | 2009 | 48 | 0.080 |
Why?
| Research Design | 2 | 2008 | 344 | 0.080 |
Why?
| Medical History Taking | 1 | 2009 | 47 | 0.080 |
Why?
| Patient Preference | 1 | 2009 | 38 | 0.080 |
Why?
| Anthropometry | 2 | 2006 | 92 | 0.080 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 247 | 0.080 |
Why?
| Surgical Procedures, Operative | 1 | 2009 | 66 | 0.080 |
Why?
| Attitude to Death | 1 | 2008 | 12 | 0.080 |
Why?
| Meta-Analysis as Topic | 1 | 2008 | 38 | 0.080 |
Why?
| Emergency Treatment | 2 | 2008 | 30 | 0.080 |
Why?
| Cardiotocography | 2 | 2005 | 8 | 0.080 |
Why?
| Forecasting | 2 | 2007 | 145 | 0.080 |
Why?
| Pregnancy, Ectopic | 1 | 2008 | 9 | 0.080 |
Why?
| Brain | 1 | 2016 | 1311 | 0.080 |
Why?
| Asphyxia Neonatorum | 2 | 2010 | 8 | 0.080 |
Why?
| Creatinine | 2 | 2006 | 142 | 0.080 |
Why?
| Fecal Incontinence | 1 | 2008 | 12 | 0.080 |
Why?
| Societies, Medical | 2 | 2006 | 177 | 0.080 |
Why?
| Constipation | 1 | 2008 | 33 | 0.070 |
Why?
| Spectrophotometry | 2 | 1999 | 32 | 0.070 |
Why?
| p-Aminohippuric Acid | 2 | 1999 | 11 | 0.070 |
Why?
| Administration, Intravenous | 2 | 2020 | 70 | 0.070 |
Why?
| Genetic Diseases, Inborn | 2 | 1999 | 23 | 0.070 |
Why?
| Perinatal Mortality | 2 | 2020 | 3 | 0.070 |
Why?
| Double-Blind Method | 3 | 2020 | 682 | 0.070 |
Why?
| Nurse's Role | 1 | 2007 | 67 | 0.070 |
Why?
| Sepsis | 3 | 2009 | 226 | 0.070 |
Why?
| Breast Feeding | 1 | 2009 | 189 | 0.070 |
Why?
| Abortion, Induced | 2 | 1998 | 19 | 0.070 |
Why?
| Body Size | 1 | 2007 | 27 | 0.070 |
Why?
| Glucocorticoids | 2 | 2016 | 230 | 0.070 |
Why?
| Antacids | 1 | 2006 | 11 | 0.070 |
Why?
| Workload | 1 | 2006 | 43 | 0.070 |
Why?
| Thinness | 1 | 2006 | 45 | 0.070 |
Why?
| Drug Administration Schedule | 4 | 2011 | 369 | 0.070 |
Why?
| Ludwig's Angina | 1 | 2006 | 1 | 0.070 |
Why?
| Gastroesophageal Reflux | 1 | 2006 | 50 | 0.070 |
Why?
| Thrombocytopenia | 4 | 2000 | 84 | 0.060 |
Why?
| Mesothelioma | 1 | 2005 | 18 | 0.060 |
Why?
| Comorbidity | 2 | 2023 | 612 | 0.060 |
Why?
| Leptin | 1 | 2007 | 143 | 0.060 |
Why?
| Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 7 | 0.060 |
Why?
| Uterine Neoplasms | 1 | 2005 | 60 | 0.060 |
Why?
| Acid-Base Imbalance | 1 | 2005 | 1 | 0.060 |
Why?
| Aspartate Aminotransferases | 4 | 2001 | 47 | 0.060 |
Why?
| Gene Frequency | 3 | 2010 | 96 | 0.060 |
Why?
| Analgesics | 1 | 2006 | 103 | 0.060 |
Why?
| Liver Neoplasms | 1 | 2009 | 331 | 0.060 |
Why?
| Colonic Pseudo-Obstruction | 1 | 2004 | 3 | 0.060 |
Why?
| Hypoglycemia | 1 | 2005 | 52 | 0.060 |
Why?
| Antibiotic Prophylaxis | 1 | 2005 | 61 | 0.060 |
Why?
| Pain, Postoperative | 1 | 2006 | 160 | 0.060 |
Why?
| Vagina | 2 | 2011 | 45 | 0.060 |
Why?
| Workplace | 1 | 2005 | 92 | 0.060 |
Why?
| Proteins | 1 | 2007 | 348 | 0.060 |
Why?
| Statistics, Nonparametric | 3 | 2011 | 193 | 0.060 |
Why?
| Calcium | 1 | 2006 | 400 | 0.060 |
Why?
| False Positive Reactions | 3 | 2007 | 62 | 0.060 |
Why?
| Pelvic Inflammatory Disease | 1 | 2004 | 8 | 0.060 |
Why?
| Biophysics | 2 | 2004 | 16 | 0.060 |
Why?
| Thrombophlebitis | 1 | 2004 | 24 | 0.060 |
Why?
| Arterial Pressure | 1 | 2024 | 44 | 0.060 |
Why?
| Palliative Care | 1 | 2006 | 188 | 0.060 |
Why?
| Glycoproteins | 1 | 2004 | 115 | 0.060 |
Why?
| Urogenital System | 1 | 2003 | 5 | 0.060 |
Why?
| Pregnancy Trimesters | 2 | 2017 | 9 | 0.060 |
Why?
| Swimming | 1 | 2003 | 22 | 0.060 |
Why?
| Infusion Pumps | 1 | 2003 | 13 | 0.050 |
Why?
| Platelet Storage Pool Deficiency | 1 | 2003 | 1 | 0.050 |
Why?
| Injections, Subcutaneous | 1 | 2003 | 51 | 0.050 |
Why?
| Recurrence | 2 | 2003 | 660 | 0.050 |
Why?
| Outpatients | 1 | 2004 | 115 | 0.050 |
Why?
| Weights and Measures | 1 | 2002 | 4 | 0.050 |
Why?
| Sphingomyelins | 2 | 2000 | 8 | 0.050 |
Why?
| Propionates | 1 | 2003 | 22 | 0.050 |
Why?
| Phosphatidylcholines | 2 | 2000 | 26 | 0.050 |
Why?
| Multiple Organ Failure | 1 | 2003 | 47 | 0.050 |
Why?
| Kidney Diseases | 1 | 2005 | 212 | 0.050 |
Why?
| Emergencies | 2 | 2021 | 80 | 0.050 |
Why?
| Pregnancy Tests | 1 | 2002 | 2 | 0.050 |
Why?
| Autopsy | 1 | 2022 | 47 | 0.050 |
Why?
| Hospital Costs | 1 | 2003 | 72 | 0.050 |
Why?
| Ovarian Diseases | 1 | 2002 | 2 | 0.050 |
Why?
| Blood Pressure Determination | 2 | 2003 | 40 | 0.050 |
Why?
| Gels | 2 | 2002 | 21 | 0.050 |
Why?
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2002 | 6 | 0.050 |
Why?
| Tissue Expansion | 1 | 2002 | 4 | 0.050 |
Why?
| Health Promotion | 1 | 2005 | 264 | 0.050 |
Why?
| Surgical Instruments | 1 | 2002 | 27 | 0.050 |
Why?
| Disseminated Intravascular Coagulation | 2 | 1999 | 6 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 28 | 0.050 |
Why?
| Contrast Media | 1 | 2003 | 186 | 0.050 |
Why?
| Wound Healing | 2 | 1994 | 203 | 0.050 |
Why?
| Risk | 3 | 2013 | 315 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 3 | 2006 | 1356 | 0.050 |
Why?
| Proteinuria | 3 | 1999 | 39 | 0.050 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 337 | 0.050 |
Why?
| Injections, Intramuscular | 3 | 2009 | 51 | 0.050 |
Why?
| Shoulder | 2 | 2008 | 19 | 0.040 |
Why?
| Leukocytosis | 1 | 2000 | 12 | 0.040 |
Why?
| Ambulatory Care | 1 | 2002 | 225 | 0.040 |
Why?
| Respiration | 1 | 2000 | 100 | 0.040 |
Why?
| Models, Theoretical | 2 | 1999 | 174 | 0.040 |
Why?
| Intensive Care Units | 1 | 2021 | 224 | 0.040 |
Why?
| Sodium Chloride | 2 | 1998 | 58 | 0.040 |
Why?
| Reoperation | 1 | 2002 | 454 | 0.040 |
Why?
| Blood Gas Analysis | 2 | 2003 | 31 | 0.040 |
Why?
| Disorders of Sex Development | 1 | 1999 | 7 | 0.040 |
Why?
| Embryo Transfer | 1 | 2019 | 18 | 0.040 |
Why?
| Mental Health | 1 | 2022 | 223 | 0.040 |
Why?
| Animals | 1 | 2014 | 13141 | 0.040 |
Why?
| Erythrocyte Count | 1 | 1999 | 3 | 0.040 |
Why?
| Fetal Hemoglobin | 1 | 1999 | 5 | 0.040 |
Why?
| Fetomaternal Transfusion | 1 | 1999 | 3 | 0.040 |
Why?
| Placentation | 1 | 2019 | 12 | 0.040 |
Why?
| Lung Diseases | 1 | 2000 | 97 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2020 | 480 | 0.040 |
Why?
| Genotype | 2 | 2010 | 542 | 0.040 |
Why?
| Trophoblasts | 1 | 2019 | 29 | 0.040 |
Why?
| Palpation | 1 | 1998 | 7 | 0.040 |
Why?
| Weather | 1 | 1998 | 3 | 0.040 |
Why?
| Obstetrical Forceps | 2 | 2015 | 5 | 0.040 |
Why?
| Labor Presentation | 1 | 1998 | 1 | 0.040 |
Why?
| Dilatation and Curettage | 2 | 1998 | 2 | 0.040 |
Why?
| Alanine Transaminase | 2 | 1999 | 120 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 213 | 0.040 |
Why?
| Databases, Factual | 2 | 2015 | 660 | 0.040 |
Why?
| Gaucher Disease | 1 | 1998 | 15 | 0.040 |
Why?
| Costs and Cost Analysis | 1 | 1998 | 92 | 0.040 |
Why?
| Skull | 2 | 1995 | 77 | 0.040 |
Why?
| Carboprost | 1 | 1998 | 1 | 0.040 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 1998 | 2 | 0.040 |
Why?
| Cerebral Hemorrhage | 2 | 2014 | 99 | 0.040 |
Why?
| Critical Care | 1 | 2000 | 215 | 0.040 |
Why?
| Treatment Failure | 2 | 2009 | 116 | 0.040 |
Why?
| Patient Discharge | 1 | 2000 | 322 | 0.040 |
Why?
| Georgia | 1 | 2017 | 42 | 0.040 |
Why?
| APACHE | 1 | 2017 | 23 | 0.040 |
Why?
| Evaluation Studies as Topic | 2 | 1998 | 110 | 0.040 |
Why?
| Embryonic and Fetal Development | 1 | 1997 | 20 | 0.040 |
Why?
| Indicator Dilution Techniques | 2 | 1997 | 12 | 0.040 |
Why?
| Nicotine | 1 | 2018 | 182 | 0.040 |
Why?
| Self Care | 1 | 1998 | 135 | 0.030 |
Why?
| Isotonic Solutions | 1 | 1996 | 18 | 0.030 |
Why?
| Water-Electrolyte Imbalance | 1 | 1996 | 15 | 0.030 |
Why?
| Chlorides | 1 | 1996 | 50 | 0.030 |
Why?
| Suture Techniques | 2 | 1994 | 59 | 0.030 |
Why?
| Therapeutic Irrigation | 2 | 1993 | 29 | 0.030 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 185 | 0.030 |
Why?
| Transportation | 1 | 2016 | 31 | 0.030 |
Why?
| Flow Cytometry | 1 | 1999 | 475 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 322 | 0.030 |
Why?
| Psychometrics | 1 | 2017 | 228 | 0.030 |
Why?
| Dinoprost | 1 | 1995 | 8 | 0.030 |
Why?
| Cephalopelvic Disproportion | 1 | 2015 | 2 | 0.030 |
Why?
| Rupture | 1 | 2015 | 24 | 0.030 |
Why?
| Depressive Disorder, Major | 1 | 2017 | 150 | 0.030 |
Why?
| Florida | 1 | 1995 | 58 | 0.030 |
Why?
| Occupations | 1 | 1995 | 17 | 0.030 |
Why?
| Fracture Fixation | 1 | 2015 | 17 | 0.030 |
Why?
| Urogenital Abnormalities | 1 | 2015 | 17 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 347 | 0.030 |
Why?
| Administration, Rectal | 1 | 2015 | 10 | 0.030 |
Why?
| Teratoma | 1 | 1995 | 26 | 0.030 |
Why?
| Sexual Behavior | 1 | 2016 | 115 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 298 | 0.030 |
Why?
| Hematologic Tests | 1 | 1995 | 10 | 0.030 |
Why?
| Liver Function Tests | 1 | 1995 | 46 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 1999 | 459 | 0.030 |
Why?
| Discriminant Analysis | 1 | 1994 | 27 | 0.030 |
Why?
| Cervical Length Measurement | 1 | 2014 | 1 | 0.030 |
Why?
| Radiography | 1 | 2015 | 485 | 0.030 |
Why?
| Interleukin-8 | 1 | 1994 | 86 | 0.030 |
Why?
| Stress, Physiological | 1 | 1995 | 174 | 0.030 |
Why?
| Enterocolitis, Necrotizing | 1 | 2014 | 36 | 0.030 |
Why?
| Drug Administration Routes | 1 | 2013 | 10 | 0.030 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2014 | 71 | 0.030 |
Why?
| Povidone-Iodine | 1 | 1993 | 7 | 0.030 |
Why?
| Biometry | 3 | 2000 | 21 | 0.030 |
Why?
| Interleukin-6 | 1 | 1994 | 266 | 0.030 |
Why?
| Maternal Welfare | 2 | 2004 | 9 | 0.030 |
Why?
| Leukocyte Count | 2 | 2004 | 72 | 0.030 |
Why?
| New Zealand | 1 | 2012 | 18 | 0.030 |
Why?
| Ascites | 1 | 1992 | 29 | 0.030 |
Why?
| Auscultation | 1 | 2012 | 9 | 0.030 |
Why?
| Health Care Surveys | 1 | 2012 | 173 | 0.020 |
Why?
| Disease Progression | 1 | 1995 | 821 | 0.020 |
Why?
| Injections, Intravenous | 2 | 2003 | 137 | 0.020 |
Why?
| Canada | 1 | 2012 | 104 | 0.020 |
Why?
| Self Report | 1 | 2013 | 202 | 0.020 |
Why?
| Patient Safety | 1 | 2012 | 102 | 0.020 |
Why?
| Brain Neoplasms | 1 | 1995 | 286 | 0.020 |
Why?
| Oximetry | 1 | 2012 | 65 | 0.020 |
Why?
| Area Under Curve | 1 | 2011 | 178 | 0.020 |
Why?
| Models, Biological | 1 | 1994 | 722 | 0.020 |
Why?
| Models, Statistical | 1 | 2012 | 225 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 234 | 0.020 |
Why?
| Chromogranins | 1 | 2010 | 5 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 13 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2010 | 22 | 0.020 |
Why?
| Uric Acid | 2 | 1999 | 23 | 0.020 |
Why?
| Medical Informatics | 1 | 2010 | 48 | 0.020 |
Why?
| Nausea | 2 | 1999 | 48 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2010 | 159 | 0.020 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 55 | 0.020 |
Why?
| Appendectomy | 1 | 2009 | 32 | 0.020 |
Why?
| Western Australia | 1 | 2008 | 6 | 0.020 |
Why?
| Vomiting | 2 | 1999 | 73 | 0.020 |
Why?
| Virginia | 1 | 2008 | 19 | 0.020 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 108 | 0.020 |
Why?
| Flatulence | 1 | 2008 | 3 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 136 | 0.020 |
Why?
| Rectum | 1 | 2008 | 52 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2007 | 37 | 0.020 |
Why?
| Shoulder Fractures | 1 | 2007 | 7 | 0.020 |
Why?
| Fathers | 1 | 2007 | 24 | 0.020 |
Why?
| Pedigree | 1 | 2007 | 125 | 0.020 |
Why?
| Pelvic Floor | 1 | 2008 | 51 | 0.020 |
Why?
| Wisconsin | 1 | 2007 | 44 | 0.020 |
Why?
| Femur | 2 | 2000 | 132 | 0.020 |
Why?
| Liver | 2 | 2009 | 1122 | 0.020 |
Why?
| Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 5 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2008 | 226 | 0.020 |
Why?
| Heart Failure | 1 | 1992 | 508 | 0.020 |
Why?
| Cytodiagnosis | 1 | 2005 | 42 | 0.020 |
Why?
| Insurance, Liability | 1 | 2005 | 1 | 0.020 |
Why?
| Compensation and Redress | 1 | 2005 | 2 | 0.020 |
Why?
| Registries | 1 | 2008 | 527 | 0.020 |
Why?
| Liability, Legal | 1 | 2005 | 12 | 0.020 |
Why?
| Diagnosis-Related Groups | 1 | 2005 | 18 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2005 | 15 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 192 | 0.020 |
Why?
| Diastole | 1 | 2005 | 71 | 0.020 |
Why?
| Washington | 1 | 2005 | 47 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2005 | 100 | 0.020 |
Why?
| Pain Measurement | 1 | 2006 | 246 | 0.020 |
Why?
| Cecostomy | 1 | 2004 | 4 | 0.020 |
Why?
| Phenotype | 1 | 2007 | 732 | 0.010 |
Why?
| Delivery Rooms | 1 | 2004 | 1 | 0.010 |
Why?
| Overweight | 1 | 2006 | 215 | 0.010 |
Why?
| Decision Making | 1 | 2006 | 273 | 0.010 |
Why?
| Wound Infection | 1 | 2004 | 27 | 0.010 |
Why?
| Suicide | 1 | 2005 | 82 | 0.010 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2004 | 27 | 0.010 |
Why?
| Injury Severity Score | 1 | 2004 | 161 | 0.010 |
Why?
| Vancomycin | 1 | 2004 | 79 | 0.010 |
Why?
| Fetal Hypoxia | 1 | 2003 | 2 | 0.010 |
Why?
| Resuscitation | 1 | 2003 | 73 | 0.010 |
Why?
| Polyunsaturated Alkamides | 1 | 2003 | 3 | 0.010 |
Why?
| Heparin | 1 | 2004 | 91 | 0.010 |
Why?
| Fever | 1 | 2004 | 110 | 0.010 |
Why?
| Fibrinolytic Agents | 1 | 2004 | 126 | 0.010 |
Why?
| Neutrophils | 1 | 2004 | 148 | 0.010 |
Why?
| Organ Size | 1 | 2003 | 223 | 0.010 |
Why?
| Hypothyroidism | 1 | 2003 | 54 | 0.010 |
Why?
| Tachycardia, Paroxysmal | 1 | 2002 | 8 | 0.010 |
Why?
| Laparotomy | 1 | 2002 | 35 | 0.010 |
Why?
| Uterine Cervical Diseases | 1 | 2002 | 3 | 0.010 |
Why?
| Heart Rate | 1 | 2003 | 301 | 0.010 |
Why?
| Placebos | 1 | 2002 | 85 | 0.010 |
Why?
| Ovariectomy | 1 | 2002 | 113 | 0.010 |
Why?
| Diuresis | 1 | 2001 | 11 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2006 | 562 | 0.010 |
Why?
| Survival Analysis | 1 | 2002 | 670 | 0.010 |
Why?
| Karyotyping | 1 | 1999 | 83 | 0.010 |
Why?
| Asthma | 1 | 2003 | 282 | 0.010 |
Why?
| Headache | 1 | 1999 | 76 | 0.010 |
Why?
| Liver Diseases | 1 | 1999 | 79 | 0.010 |
Why?
| Pulse | 1 | 1998 | 15 | 0.010 |
Why?
| Stomach | 1 | 1999 | 80 | 0.010 |
Why?
| Injections | 1 | 1998 | 57 | 0.010 |
Why?
| Mathematics | 1 | 1998 | 45 | 0.010 |
Why?
| Heart Arrest | 1 | 1999 | 151 | 0.010 |
Why?
| Blood | 1 | 1997 | 27 | 0.010 |
Why?
| Acidosis, Respiratory | 1 | 1997 | 2 | 0.010 |
Why?
| Blood Specimen Collection | 1 | 1997 | 34 | 0.010 |
Why?
| Twin Studies as Topic | 1 | 1996 | 3 | 0.010 |
Why?
| Pain | 1 | 1999 | 373 | 0.010 |
Why?
| Inflammation | 1 | 2000 | 608 | 0.010 |
Why?
| Diagnostic Tests, Routine | 1 | 1995 | 29 | 0.010 |
Why?
| Feasibility Studies | 1 | 1997 | 383 | 0.010 |
Why?
| Extraction, Obstetrical | 1 | 1992 | 3 | 0.010 |
Why?
| Nerve Compression Syndromes | 1 | 1992 | 6 | 0.010 |
Why?
| Granulation Tissue | 1 | 1992 | 10 | 0.010 |
Why?
| Debridement | 1 | 1992 | 45 | 0.010 |
Why?
| Anemia, Hemolytic | 1 | 1992 | 11 | 0.010 |
Why?
| Random Allocation | 1 | 1992 | 288 | 0.010 |
Why?
| Syndrome | 1 | 1992 | 239 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 1994 | 281 | 0.010 |
Why?
|
|
Magann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|